These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Studies on Alternaria allergens. IV. Biologic activity of a purified Alternaria fraction (Alt-I).
    Author: Miles RM, Parker JL, Jones RT, Dahlberg MJ, Yunginger JW.
    Journal: J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):36-9. PubMed ID: 6185555.
    Abstract:
    We have previously isolated a purified Alternaria fraction (Alt-I) by means of immunochemical (RAST) assays to document allergenicity. In the present study we investigated the allergenicity of Alt-I by in vivo and in vitro biologic tests in a selected group of 16 nonimmunized Alternaria-sensitive patients, all of whom had positive skin tests to crude Alternaria extract; a control group of eight nonallergic individuals was also studied. Intradermal skin-test titration endpoints to Alt-I ranged from 60 pg/ml to 60 ng/ml in the Alternaria-sensitive patients. Alt-I induced greater than 30% in vitro leukocyte histamine in all Alternaria-sensitive patients at submicrogram concentrations. Alt-I did not produce positive skin tests or induce significant leukocyte histamine release in nonallergic individuals. In 14 of 16 Alternaria-sensitive patients bronchoprovocation testing produced greater than 20% fall in forced expiratory volume in one second at Alt-I test concentrations of 0.6 to 60 micrograms/ml. In a separate prospective study of 100 unselected individuals, concordant skin-test reactions were noted to crude Alternaria extract and Alt-I in 96 instances. These results confirm that the Alt-I fraction is a biologically active, major allergenic component of crude Alternaria extract.
    [Abstract] [Full Text] [Related] [New Search]